MM19: A Phase 3 trial of thalidomide-dexamethasone consolidation versus thalidomide-dexamethasoneIxazomib consolidation for transplant eligible multiple myeloma patients undergoing a single ASCT as part of front-line therapy

Project: Research

StatusActive
Effective start/end date3/04/172/04/22